RFRobert Fitridge

Robert Fitridge

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Robert Fitridge has a total of 236 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Autophagic flux is increased in peripheral blood mononuclear cells in atherosclerotic vascular disease and associates inversely with adverse cardiovascular events

    by Bronwyn Beelders, Leanne K. Hein, Naomi Wattchow, Mau T. Nguyen, Shabnam Torabiardakani, Thalia Salagaras, Sanuri Liyanage, Christina A. Bursill, Robert Fitridge, Neil McMillan, et al.

    Background: Autophagy is a homeostatic pathway supporting stress adaptation and is dysregulated in atherosclerosis. Its potential as a biomarker or therapeutic target in atherosclerotic vascular disease (ASVD) remains incompletely defined. We measured autophagic flux in peripheral blood mononuclear cells (PBMCs) from patients with peripheral arterial disease (PAD) or carotid stenosis (CS), compared with healthy controls, and explored clinical outcome associations. Methods: Ninety-four patients with PAD or CS and 19 healthy controls were studied. Autophagic flux was quantified from fresh blood using a validated ex vivo chloroquine-inhibition ELISA measuring LC3B-II accumulation. Major adverse cardiovascular events (MACE) and major adverse limb events (MALE) were ascertained over a median follow-up of 828 days. Results: The ASVD cohort comprised claudication (n = 16), chronic limb-threatening ischemia (CLTI; n = 49), and CS (n = 29). Autophagic flux was higher in ASVD than controls (mean 281.4 vs. 182.3 ng LC3B-II/mg protein/h; p < 0.0001) and remained independently associated after multivariable adjustment. Within CLTI, concurrent infection was associated with lower flux (p = 0.001), approaching control levels (p = 0.327). In CLTI, higher flux quartiles were associated with lower MACE risk, most strongly for quartile 3 (hazard ratio 0.07 vs. quartile 1, 95% CI 0.01–0.50; p = 0.009). Conclusion: Autophagic flux is elevated in PBMCs from ASVD patients, independent of age and sex. Attenuated flux in CLTI with concurrent infection may indicate autophagic exhaustion in advanced disease. The association between higher flux and lower MACE in CLTI suggests prognostic utility, warranting evaluation in larger prospective studies.

  • Pathophysiology and Principles of Management of Diabetes-Related Foot Complications

    by Guilherme Pena, Vivienne Chuter, David G. Armstrong, Joseph L. Mills, Robert Fitridge

  • Pathophysiology of Reperfusion Injury

    by Prue Cowled, Robert Fitridge

  • Open Access

    Development of a core descriptor set for studies assessing interventions for diabetes-related foot ulceration

    by Aleksandra Staniszewska, Amy Jones, Luke Davies, Frances Game, Jane Nixon, David Russell, Sicco A. Bus, Jayer Chung, Vivienne Chuter, Ketan Dhatariya, et al.

    Aims/hypothesis: Foot ulceration is a common complication of diabetes and is associated with high mortality and costs. The quality of evidence to inform clinical practice is limited, partly because clinical studies do not consistently report baseline participant characteristics. This study aimed to develop a core descriptor set (CDS), a minimum set of descriptors to be measured in all studies evaluating interventions for people with diabetes-related foot ulceration. Methods: A longlist of descriptors was generated through a systematic review of studies assessing interventions for diabetes-related foot ulcers, pre-registered with PROSPERO (CRD42019128250). The identified descriptors were then ranked based on perceived importance by healthcare professionals from different fields and geographical locations using a nine-point Likert scale in the first round of a Delphi survey. Using standardised criteria, descriptors without consensus were re-ranked in round two. Critical descriptors and those without consensus after the Delphi process were discussed in the consensus meeting to finalise the CDS. Results: The systematic review yielded 95 candidate descriptors. The two Delphi rounds were completed by 102 and 69 healthcare professionals, respectively. The Delphi process identified 34 critically important descriptors and 13 descriptors without consensus, which were discussed in the consensus meeting. The ratified CDS included 28 descriptors across nine domains: demographic variables; individual factors; ulcer characteristics; limb characteristics; ongoing medical interventions; previous surgical interventions; medication history; biochemical measurements; and quality of life/function/symptoms. Conclusions/interpretation: This CDS reflects characteristics important to health professionals and researchers when reporting clinical studies on diabetes-related foot ulceration. Its use will aid the reporting of future studies.


  • Open Access

    Acceptability and Utility of a Virtual Reality Diabetes‐Related Foot Disease Training Program for First Nations People: A Pragmatic Quasi‐Experimental Case Series Study

    by Neil McMillan, Ancret Szpak, Zygmunt Szpak, Hannah Snelling, Joseph Agius, Cathy Loughry, Kristin Graham, Sara Jones, Tinarra Ataata, Kim Morey, et al.

    Objective: To test the utility and acceptability of a novel VR training tool for community health practitioners in assessing diabetes‐related foot disease in Aboriginal and Torres Strait Islander people. Methods: The VR program featured five virtual patient models and a range of interactive assessments covering essential clinical and triage skills. Design: Pragmatic quasi‐experimental case series. Setting: The VR training program was completed in collaboration with three Aboriginal Community‐Controlled Health Organisations in regional South Australia, with recruitment directed internally at each organisation. Participants: Forty‐one primary healthcare staff participated, of which 34 were matched on pre‐ and post‐VR surveys and 20 completed at least three training scenarios. Main Outcome Measures: Evaluation consisted of pre‐test self‐efficacy scores immediately prior to participants undergoing training, submission of post‐test self‐efficacy scores, the System Usability Scale, and Training Evaluation Inventory scores after completing all training modules. Results: Following completion of VR training, participants reported increased self‐efficacy scores ( n = 20) for performing key assessment and triage skills. User feedback ( n = 39) demonstrated that participants generally agreed that the training user experience was engaging, acceptable, and of value for clinical education. Conclusion: Community health practitioners generally found the VR training tool acceptable, useful, and increased their self‐confidence in assessing and managing diabetes‐related foot disease for Aboriginal and Torres Strait Islander people, highlighting the potential of VR to upskill community practitioners.

  • Open Access

    The Australia and N ew Z ealand Diabetic and Ischaemic Foot Outcomes Study ( ANZDIFOS )

    by Odette Hart, Philip Allan, Shirley Jansen, Robert Fitridge, Claire Murray, Mendel Baba, Prue Cowled, Neil McMillan, Manar Khashram

    Objective: There is limited high‐quality data on the factors that contribute to limb loss in patients with diabetes‐related foot disease (DFD) in New Zealand and Australia. Furthermore, wound, ischaemia and foot infection (WIfI) staging has not been validated in the Australasian cohort. The aim of this study was to (1) report on the presentation, management and outcomes of DFD (wound healing, major limb amputation [MLA], amputation‐free survival [AFS] and mortality at 1‐year), and (2) validate the association of WIfI stage on outcomes. Methods: This was an observational prospective study of patients with DFD and a wound at three centres in New Zealand and Australia from 2020 to 2022. Data on presentation, management, amputation and mortality at 1‐year was collected. Outcomes were stratified by presenting WIfI stage. Wound healing and survival were assessed with Kaplan–Meier curves, time‐to‐healing with Fine‐Gray competing risks, AFS with logistic regression and survival with Cox proportional hazards. Results: Two hundred and seventy‐six patients (384 limbs) were recruited, with WIfI stage 1 (47.9%), 2 (21.1%), 3 (19.5%) and 4 (12.5%). At 1‐year, 71.4% of wounds healed, with WIfI stage associated with healing, p < 0.001. At 1‐year 16.6% of limbs had underwent a MLA, with the proportion increasing by WIfI stage. Poorer AFS was observed with increasing WIfI. Mortality at 1‐year increased with WIfI stage, p < 0.001. Conclusion: This study reports on the presentation, management and outcomes from DFD in New Zealand and Australia. WIfI staging appropriately classifies patients with DFD and correlates with healing, MLA, AFS and survival at 1‐year.